By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Intra-Cellular Therapies, Inc. 

3960 Broadway

New York  New York  10032  U.S.A.
Phone: 212-923-3344 Fax: 212-923-3388


SEARCH JOBS


Industry
Biotechnology






Company News
Intra-Cellular Therapies, Inc.'s Dementia Drug Meets Phase 1/2 Goals 10/13/2014 6:33:20 AM
Intra-Cellular Therapies, Inc. To Present Results From Phase 1/2 Clinical Trial For ITI-007 In Healthy Geriatric Subjects And Patients With Dementia At The American Neurological Association 139th Annual Meeting 10/7/2014 7:24:39 AM
Intra-Cellular Therapies, Inc. Reports Financial Results For Second Quarter Ended June 30, 2014 8/12/2014 8:07:50 AM
Intra-Cellular Therapies, Inc. To Host Conference Call On Tuesday, August 12, At 8:30 Am Eastern Time, On Second Quarter 2014 Financial Results 8/5/2014 3:28:41 PM
Intra-Cellular Therapies, Inc. Announces The Appointment Of Michael Halstead As Senior Vice President And General Counsel 7/31/2014 10:33:59 AM
Intra-Cellular Therapies, Inc. To Be Added To The Russell 3000® And Russell 2000® Indexes 6/30/2014 8:16:20 AM
Intra-Cellular Therapies, Inc. To Participate In A Fireside Chat At The 9th Annual JMP Securities Healthcare Conference 6/13/2014 8:21:22 AM
Intra-Cellular Therapies, Inc. To Present At Upcoming Scientific Conferences 6/13/2014 7:55:13 AM
Intra-Cellular Therapies, Inc. Presents New Data From The Phase 2 Clinical Trial Of ITI-007 In Schizophrenia At The 167th Annual Meeting Of The American Psychiatric Association 5/7/2014 9:13:28 AM
Intra-Cellular Therapies, Inc. Reports First Quarter 2014 Financial Results 5/6/2014 9:22:48 AM
1234
//-->